AbbVie shares are trading higher after the company reported better-than-expected Q3 financial results and raised its FY24 adjusted EPS guidance above estimates.
Portfolio Pulse from Benzinga Newsdesk
AbbVie shares rose following the release of strong Q3 financial results and an increase in FY24 adjusted EPS guidance.
October 30, 2024 | 3:03 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
AbbVie shares increased due to better-than-expected Q3 results and an upward revision of FY24 EPS guidance.
The company's strong Q3 financial performance and increased FY24 EPS guidance are likely to boost investor confidence, leading to a positive short-term impact on the stock price.
CONFIDENCE 100
IMPORTANCE 90
RELEVANCE 100